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Abstract
After their disappearance from the human population in 1968, influenza H2 viruses have 
continued to circulate in the natural avian reservoir. The isolation of this virus subtype from 
multiple bird species as well as swine highlights the need to better understand the potential of 
these viruses to spread and cause disease in humans. Here we analyzed the virulence, 
transmissibility and receptor-binding preference of two avian influenza H2 viruses (H2N2 and 
H2N3) and compared them to a swine H2N3 (A/swine/Missouri/2124514/2006 [swMO]), and a 
human H2N2 (A/England/10/1967 [Eng/67]) virus using the ferret model as a mammalian host. 
Both avian H2 viruses possessed the capacity to spread efficiently between cohoused ferrets, and 
the swine (swMO) and human (Eng/67) viruses transmitted to naïve ferrets by respiratory droplets. 
Further characterization of the swMO hemagglutinin (HA) by x-ray crystallography and glycan 
microarray array identified receptor-specific adaptive mutations. As influenza virus quasispecies 
dynamics during transmission have not been well characterized, we sequenced nasal washes 
collected during transmission studies to better understand experimental adaptation of H2 HA. The 
avian H2 viruses isolated from ferret nasal washes contained mutations in the HA1, including a 
Gln226Leu substitution, which is a mutation associated with α2,6 sialic acid (human-like) binding 
preference. These results suggest that the molecular structure of HA in viruses of the H2 subtype 
continue to have the potential to adapt to a mammalian host and become transmissible, after 
acquiring additional genetic markers.
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Introduction
The 1957 Asian influenza pandemic was caused by an influenza virus of the H2N2 subtype. 
H2N2 viruses established a stable presence in humans for 11 years and caused 
approximately 2 million deaths worldwide before they disappeared from human circulation 
following the emergence of the 1968 pandemic H3N2 virus (Simonsen et al., 1998). The 
reintroduction of the H2 subtype into the human population would pose a significant global 
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health threat in a population where the majority of humans now lack anti-H2 hemagglutinin 
(HA) serologic immunity (Pyhala 1985; Webster 1997; Nabel et al., 2011). Avian influenza 
virus surveillance provides evidence for the continuing circulation of H2 viruses in wild 
migratory birds and poultry in live bird markets (Schafer et al., 1993; Piaggio et al., 2012; 
Chen et al., 2010). In some cases, contemporary H2 viruses have been found to be 
antigenically related to the early pandemic human viruses (Schafer et al., 1993; Piaggio et 
al., 2012; Chen et al., 2010). Moreover, currently circulating avian H2 virus reassortants 
containing gene segments from both Eurasian and North American lineages have been found 
in North American wild birds, indicating that genetic reassortment is occurring for this 
subtype and novel H2 viruses are being generated (Piaggio et al., 2012; Makarova et al., 
1999; Liu et al., 2004; Kishida et al., 2008; Ferro et al., 2010; Ramey et al., 2010).
Zoonotic influenza viruses are constantly emerging from avian (H9N2, H5N1, H7N9) and 
swine species (H1N1, H1N2, H3N2) to sporadically infect humans, mainly through 
exposure to infected animals or contaminated environments (http://www.who.int/en/). 
Individuals exposed to avian influenza viruses may present a range of clinical manifestations 
from asymptomatic to more serious complications of the respiratory tract that can even lead 
to death (World Health Organization, 2013). Although H5 and H7 subtype viruses have 
received the greatest attention as potential pandemic threats, the concept of pandemic 
recycling in humans has been proposed and validated by the reemergence of swine origin 
H1N1 pandemic virus in 2009 (Dowdle, 2006). Should an avian influenza H2 virus emerge 
that possesses the ability to infect swine productively, the pandemic potential of such a virus 
would be substantial. In 2006, H2N3 subtype influenza viruses were isolated from pigs in 
two swine farms in the U.S. (Ma et al., 2007). These viruses were characterized as 
containing 6 internal genes (PB2, PB1, PA, NP, M and NS) derived from contemporary 
North American swine triple reassortant viruses and the remaining genes (HA and NA) 
derived from avian H2 influenza viruses. The HA of both H2N3 viruses were found to be 
antigenically related to the currently circulating avian influenza viruses (Ma et al., 2007; 
Killian et al., 2011). Experimentally, these viruses were pathogenic in mice and shown to 
transmit efficiently in ferrets and pigs in direct contact models (Ma et al., 2007). The swine 
H2N3 virus was also reported to cause severe pneumonia with elevated plasma cytokine 
responses compared to human H2N2 virus in nonhuman primates (Richt et al., 2012). In 
addition, the novel H2N3 virus contained a receptor binding change (Leu at position 226; 
H3 numbering) associated with both increased binding of H2 HA to human-like α2–6 sialic 
acid (SA) receptors and enhanced respiratory droplet transmissibility in ferrets (Pappas et 
al., 2010; Viswanathan et al., 2010; Xu et al., 2010). Previous studies of 1957 H2N2 HA 
suggested that both a hydrophobic switch from Gln to Leu at 226 and a slight elongation 
(~0.5 Å) of the receptor-binding site (RBS) were critical for avian H2 HA to acquire human 
receptor specificity (Xu et al., 2010; Liu et al., 2009a).
The continuous virologic surveillance of avian and swine species in the wild, in farms and in 
live bird markets has been critical for detection of newly emerging influenza viruses and for 
assessment of potential public health risks (World Health Organization, 2013). In addition to 
the genetic and antigenic characteristics and antiviral susceptibility properties of the viruses, 
assessments of emergent influenza virus properties such as molecular markers that 
contribute to receptor binding specificity, pathogenicity and transmissibility have provided 
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substantial information related to the overall risks that viruses may pose for the human 
population (Pappas et al., 2010; Maines et al., 2011; Pearce et al., 2012; Belser et al., 2013). 
In a recent report, Jones et al. characterized a number of historic avian H2N2 viruses in two 
mammalian models and concluded that these viruses constitute a potential risk for human 
infection (Jones et al., 2014).
The molecular markers associated with increased adaptation and transmission of H2 viruses 
are not well understood. Previous results reveal a good correlation between binding affinity 
to α2,6 SA (human-like) glycan receptors and efficient respiratory droplet transmission for 
H2N2 viruses (Pappas et al., 2010). During a respiratory droplet transmission experiment in 
ferrets there was an apparent selection of a virus variant with a receptor binding site 
(Gln226Leu) mutation in the HA, which rendered the virus transmissible (Pappas et al., 
2010). This data shows that these viruses have the capability to adapt in the mammalian host 
and become transmissible when favorable genetic factors are present. The structural analyses 
of these viruses’ HAs suggest that key amino acids in both human and avian viruses provide 
a framework that allows facile switching of receptor binding preferences (Pappas et al., 
2010). Since avian H2 viral HAs are structurally similar to the human pandemic H2 viruses, 
adaptation of these viruses to the human host is plausible and of public health concern. Here 
we evaluate the relative virulence and transmissibility of genetically distinct H2 viruses in 
the ferret model. The present work also evaluated their genetic potentials for HA adaptation 
to the mammalian host.
Results
Genetic and phenotypic characteristics of the H2 viruses used in this study
For this study we chose viruses that represent each of the three major phylogenetic lineages 
of the H2 subtype (Liu et al., 2009b). The HA protein sequences of both mallMD (H2N3) 
and swMO (H2N3) viruses belong to the Western Hemisphere (North American) sub-
lineage. The avian ckPA (H2N2) HA sequences are closely related to viruses from the 
Eastern Hemisphere (Eurasian) sub-lineage and Eng67 (H2N2) virus belongs to the human 
pandemic sub-lineage, which is most closely related to Eastern Hemisphere viruses. Genetic 
analysis of the entire genome of all four viruses used in this study shows that they are 
genetically distinct due to a variety of factors such as host origin, isolation year and 
reassortment. The percentage of amino acid identity between swMO virus and the other 
three H2 viruses ranges from 80% (NS1, non-structural protein) to 99% (PA, polymerase 
acidic) (Supplementary Table 1).
The amino acid makeup of the four H2 viruses at key positions associated with virulence 
and transmission in mammalian hosts is shown in Table 1. The human Eng67 (H2N2) virus 
contains the Leu226/Ser228 constellation in the HA RBS corresponding to an expected 
binding preference to α2–6 SA (human-like) glycan receptors. This was experimentally 
confirmed in hemagglutination assays using resialylated turkey red blood cells containing 
α2–6 SA (Table 1). Eng67 also contains Lys627 in the PB2 gene which has been shown to 
be important for respiratory droplet transmission (Pappas et al., 2010; Van Hoeven et al., 
2009). In contrast, both avian H2 (ckPA and mallMD) viruses possess the Gln226/Gly228 
constellation in the HA RBS and Glu627 in the PB2 gene. Both are typical markers of avian 
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viruses that confer α2–3 SA receptor binding and poor transmissibility via aerosolized 
droplets in mammalian animal models, respectively (Pappas et al., 2010; Viswanathan et al., 
2010; Maines et al., 2006; Glaser et al., 2006). In comparison to the avian H2 HAs, the 
swine (swMO) virus possesses a mutation, Gln226Leu, which correlates with increased 
binding affinity to α2–6 SA (Rogers et al., 1983; Connor et al., 1994); swMO HA has 
Leu226/Gly228 at the RBS and was found to agglutinate both α2–6 and α2–3 sialylated 
RBCs (Table 1). swMO virus also contains Glu627 in the PB2 gene. With respect to other 
key residues in the PB2 subunit, avian influenza viruses normally contain Gly590/Gln591 
sequences in the PB2 gene; however mallMD has a Ser rather than a Gly at position 590, the 
same amino acid found in swine origin viruses. The swMO virus PB2 gene displays the 
Ser590/Arg591 constellation, also observed in viruses of swine origin and 2009 H1N1 
[A(H1N1)pdm09] viruses, which confers increased polymerase activity in human cells 
(Mehle and Doudna, 2009). In addition, swMO virus displays Ala271 in PB2, which, along 
with the Ser590/Arg591 constellation, has been reported to be critical for viral replication 
and virulence of swine viruses (Liu et al., 2012). The other markers for pathogenesis, such 
as Ser66 in the PB1-F2 gene and the presence of the PDZ domain in the NS gene, have been 
related to highly pathogenic phenotypes in other virus subtypes (Conenello et al., 2007; 
Jackson et al., 2008).
As the optimal replication temperature of influenza viruses is a determinant for virus host 
range, we evaluated the growth of the H2 viruses at either 33 °C or 37 °C. A plaque assay 
was performed using MDCK cells in order to assess the sensitivity of each virus to replicate 
at temperatures that simulate the upper (33 °C) and lower (37 °C) respiratory tracts of 
mammals (Fig. 1). As expected for a human-adapted virus, Eng67 formed visible plaques at 
both 33 °C and 37 °C, indicating its ability to replicate efficiently at both temperatures. 
Similarly, swMO virus was able to replicate efficiently at both temperatures but plaque sizes 
appeared slightly reduced at 33 °C. However, mallMD and ckPA viruses, which replicated 
well at 37 °C failed to form significant plaques at 33 °C. These results demonstrate that the 
avian H2 viruses do not replicate as well the human (H2N2) and swine (H2N3) viruses at the 
lower temperatures found in the upper airway of mammals.
Transmissibility and pathogenicity of H2 viruses in the ferret model
For direct contact (DC) transmission experiments, three animals were inoculated i.n. with 
106 EID50 of virus. Twenty-four hours later, a naïve contact ferret was introduced into the 
same cage with each inoculated ferret. Transmission was assessed by titration of infectious 
virus in nasal washes and measurement of HI antibody titers in convalescent sera of contact 
ferrets. Signs of influenza illness were also observed through the presence of fever, lethargy, 
and weight loss. As expected, Eng67 virus transmitted efficiently in the DC model; virus 
titers in the nasal washes of inoculated ferrets achieved peak mean titers of 108.1 EID50/ml 
on day 1 post inoculation (p.i.) and infectious virus was detected in the nasal washes of all 
contact animals as early as day 1 post direct contact (p.d.c.) (Suppl. Fig. 1A, Table 2). 
Contact ferrets had detectable virus up to day 7 p.d.c. and all ferrets developed high titers of 
H2N2-specific HI antibodies, confirming efficient DC transmission of Eng67 virus. Eng67-
inoculated ferrets exhibited 5% mean maximum weight loss and a maximum temperature 
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increase of 1.7 °C over baseline (Table 2), consistent with seasonal influenza virus infections 
in ferrets (Maines et al., 2006).
As was observed with the human H2N2 (Eng67) virus, the swine H2N3 (swMO) virus 
replicated efficiently in inoculated ferrets (peak mean nasal wash titers 107.4 EID50/ml) and 
transmitted to all 3 DC ferrets (Supplementary Fig. 1B, Table 2). However, swMO virus-
infected ferrets displayed greater weight loss (mean maximum weight loss of 15.3%) and 
lethargy (relative inactivity score of 1.5) compared to human H2N2 (Eng67) virus-infected 
ferrets. Among the three contact ferrets, virus was detected in nasal washes on days 1–9, and 
3/3 contact animals seroconverted to swMO virus. The avian H2 (mallMD and ckPA) 
viruses also transmitted by DC, although ckPA had fewer (2/ 3) transmission events than the 
other three H2 viruses tested and the kinetics of transmission was delayed by 5 to 7 days 
p.d.c. (Supplementary Fig. 1C and D, Table 2). Both mallMD and ckPA viruses replicated 
efficiently; infectious virus in nasal washes peaked on days 3 and 5 p.i. (mean maximum 
107.1 and 107.0 EID50/ml, respectively). Although the peak temperatures (1.7–2.3 °C) among 
ckPA- and mallMD-inoculated ferrets were relatively similar to that observed with the other 
two H2 viruses, lethargy and the weight loss was negligible (<1% to 1.1%, mean maximum 
weight loss).
We next tested the H2 viruses in the respiratory droplet (RD) transmission model, which is a 
more stringent test of virus transmissibility because it requires virus to be transmitted only 
through the exchange of air containing virus particles. The human H2N2 (Eng67) virus 
transmitted efficiently by RD, to all 3 of the 3 indirect contact ferrets, as early as day 3 post 
indirect contact (p.i.c.) (Fig. 2A). The peak mean titers of 108.3 EID50/ml on day 1 p.i. were 
similar to that observed in the DC transmission experiments. The swMO virus spread to 2 
out of 3 indirect contact ferrets and all three inoculated ferrets displayed clinical signs 
similar to that observed in the DC transmission studies (Fig. 2B and Table 2). RD 
transmission to the indirect contact ferrets was evidenced through detection of virus titers in 
one ferret (ferret#2) and seroconversion to swMO virus in a second ferret (ferret#3). 
Negative results obtained by RT-PCR using oligonucleotide primers for HA and M genes 
confirmed that RD transmission to the two indirect contact ferrets #1 and #3 did not occur 
(Fig. 2B). It is interesting that the HI titers in the sera of indirect contact ferret #3 were four 
times lower than the titer obtained for the ferret that had virus detected in the NW (ferret #2, 
Fig. 2B, Table 2). No RD transmission was observed with the avian H2 viruses, mallMD and 
ckPA; infectious virus was not detected in indirect contact ferret NWs, and no 
seroconversion of indirect contact animals was observed (Fig. 2C and D). The mallMD- and 
ckPA-inoculated ferrets presented clinical signs similar to those observed in the direct 
contact experiment (<3% mean maximum weight loss, mean nasal wash titers 106.4–7.0 
EID50/ml, and 0.9–1.6 °C mean temperature increase) (Table 2).
We also examined the ability of the H2 viruses to replicate in respiratory tract tissues and 
organs outside of the respiratory tract, including the brain. None of the four H2 viruses could 
be detected in the brain, spleen, or heart tissues on day 3 p.i. (data not shown). Examination 
of virus titers in the upper and lower respiratory tracts of ferrets revealed that the virus titers 
levels in the nasal turbinates were relatively similar for all four viruses (P>0.1) (Fig. 3). 
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swMO and mallMD viruses were recovered from ferret tracheas and lung tissues at the 
highest levels compared with that observed for Eng67 and ckPA virus infections.
Glycan binding and crystal structure of swMO HA
The RD transmission of swMO virus prompted us to perform a more detailed glycan array 
approach to analyze the repertoire of sialylated glycans recognized by swMO virus, as well 
as determine the crystal structure of the swMO HA. Glycan microarray results for swMO 
recombinant HA revealed a strong binding preference for the α2–6-linked sialosides (#41–
59) and some binding to mixed α2–3/α2–6 branched sialosides (#60–64) (Fig. 4 and 
Supplementary Table 2). By using x-ray crystallography, the structure of swMO HA was 
determined to 2.9-Å resolution (Table 3). The overall structure of swMO HA is similar to 
other reported HA structures with a globular head containing the receptor binding site (RBS) 
and vestigial esterase domain, and a membrane proximal domain with its distinctive, central 
helical stalk and HA1/HA2 cleavage site (Fig. 5A). Although eight asparagine-linked 
glycosylation sites are predicted in the swMO HA monomer, interpretable electron density 
was observed at only five sites, Asn11, Asn23, Asn164, Asn285 in HA1 and Asn154 in 
HA2. At each of these sites, only one asparagine-linked N-acetyl glucosamine could be 
interpreted. During viral replication, HA is synthesized as a single chain precursor (HA0) 
and cleaved by specific host proteases into the infectious HA1/HA2 form. In baculovirus 
expression systems, low pathogenic virus HAs, such as SwMO, possess a monobasic 
cleavage site and are normally expressed as the HA0 form. While the HA2 fusion peptide 
for the infectious HA1/HA2 form inserts into the HA2 trimerization cavity, the loop in the 
HA0 is more exposed. Three HA0 structures, with different loop conformations have been 
described: H3 (PDB ID 1HA0), H1 (PDB ID 1RD8) and H16 (PDB ID 4F23). Like the H3 
and H1 HA0 cleavage sites, swMO H2 HA0 also forms a loop-like structure, but is 
positioned further away from the glycoprotein surface. As for the H16 HA0 cleavage site, it 
forms a short α-helix structure.
The RBS, at the membrane distal end of the HA monomer, is composed of three conserved 
structural elements: a 190-helix (residues 188–194), a 220-loop (residues 221–228), and a 
130-loop (residues 134–138). In addition, highly conserved residues (Tyr98, Trp153, 
His183, and Tyr195) form the base of the pocket (Fig. 5B). Previously, mutations in the HA 
RBS of H1N1 (Glu190Asp/Gly225Asp) and H2N2/H3N2 (Gln226Leu and Gly228Ser) 
subtypes were found to be responsible for adaptation of these viruses from avian strain to 
human strain (Connor et al., 1994; Rogers and Paulson, 1983). Studies on H2 HA structures 
showed that the 226 and 228 substitutions result in a slight elongation of the RBS in Human 
H2 HA (Xu et al., 2010). SwMO RBS has Leu226 and Gly228 which is an intermediate 
state between avian and human strains. Because of the Leu226 substitution, the subtle 
movement of the 220-loop increased the α2–6-linked sialosides binding, and the glycan 
results presented here are consistent with previous studies with a 1957 human H2 HA (Xu et 
al., 2010).
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Presence of virus subpopulations in ferret tissues of the respiratory tract and nasal 
washes
HA1 is important for recognition of sialic acid receptors and efficient transmission in 
mammals (Pappas et al., 2010; Van Hoeven et al., 2009). We first performed sequence 
analysis on tissue specimens from inoculated ferrets to look for the presence of genetically 
distinct viral subpopulations. The amino acid sequences of the HA1 region corresponding to 
the nucleotides encoding the receptor binding amino acids (positions 130 through 230, H3 
numbering) were compared to those of the original viral stocks. Although no mutations were 
present in the ckPA virus stock, we found evidence of virus subpopulations containing 
amino acid changes at positions 156 and 200 among samples (day 3 p.i.) from nasal 
turbinates and lung homogenates of 3 of 3 ckPA-inoculated ferrets (Table 4). No virus RNA 
could be extracted from the trachea supernatants of ferrets infected with ckPA. Examination 
of mallMD-infected ferrets revealed that all HA1 sequences from viruses in the nasal 
turbinates, trachea, and lungs of 3/3 animals contained amino acid variability at position 212 
(Arg and/or Met). This variation was also detected in the stock virus used to inoculate ferrets 
(Table 4). In swMO virus infected tissues, the amino acid switch Leu226Gln crucial for 
change of receptor binding preference from α2–6 to α2–3 SA was observed in the tracheas 
of 2/3 ferrets but not in nasal turbinates, lung tissues or stock virus.
To determine if there were any HA1 mutations during H2 virus transmission, sequencing 
was performed on the nasal washes of ferrets used in the DC or RD transmission 
experiments. For the swMO transmission experiments, one HA1 amino acid change 
(Leu226Gln) was observed from nasal washes, and that occurred in only 1 of 6 ferrets used 
in DC or RD transmission experiments (Table 5). The virus sequence from nasal washes of 
the other swMO exposed ferrets (1/3 from RD and 3/3 from DC transmission) remained 
unchanged (sample from day 5 p.i.c./p.d.c.). The HA1 sequences of ckPA viruses that were 
collected during the DC transmission experiment revealed that the virus in both inoculated 
and contact ferrets (pairs #1 and #3) underwent two amino acid changes at positions 190 
(Glu190Gly pair #1 and Glu190Asp pair #3) and 216 (Glu216Asp) in both ferret pairs. For 
inoculated ferret #2 that did not transmit ckPA virus to its cage mate, changes were not 
present at those positions but only at amino acid 206 (Thr/Pro206). Interestingly, the 
mallMD virus from one inoculated and one unrelated DC contact ferrets had subpopulations 
with the key RBS amino acid substitution at position 226 (Gln226Leu). Additional amino 
acid changes at positions Glu190Val, Gly205Val, and Met/Arg212Arg or Met in different 
combinations were also found depending on the ferret pair of both RD and DC transmission 
experiments (Table 5).
Mixed populations during the course of mallMD infection and transmission
The appearance of Leu226 amino acid in the nasal washes of mallMD infected ferrets 
suggested a probable adaptation for this virus to replicate in mammalian tissues. We next 
performed a more in depth analysis of the nasal washes collected during the entire course of 
mallMD virus infection. RNA was extracted from each nasal wash sample of inoculated and 
contact ferrets during DC transmission experiments. Overall, viruses containing amino acid 
changes appeared early among inoculated ferrets (days 1–5 p. i.) in the course of infection 
(Table 6). Amino acids mutations that were consistently observed were Glu190Val, 
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Gly205Val, Met/Arg212Arg or Met, Gln226Leu, and 228 (silent mutation). Viruses 
containing Leu226 were not detected in the nasal washes of the ferret pair#1, but mutant 
viruses containing Gly205Val and Met/Arg212Met or Arg substitutions were present, 
appearing in inoculated ferrets on day 5 p.i. and spreading to the contact ferret on day 7 
p.d.c. In ferret pair #2, changes involving four amino acids at positions 205, 212, 226 and 
228 took place during infection among inoculated and contact ferrets. Virus was detected in 
the contact ferret on day 1 p.d.c.; mixed populations containing either Gln226 or Leu226 
were present in the nasal washes of the inoculated ferrets on day 7 p.i. and in its contact on 
days 5 and 7 p.d.c. (Table 6). The most consistent mutations that were present in the viruses 
collected from both ferrets were the Met/Arg212Met or Arg substitutions. Of note, a silent 
nucleotide mutation at residue 228 was also detected in most NW viruses carrying the 
Leu266 mutation. In ferret pair #3, amino acid changes occurred in the inoculated ferret 
starting with one HA mutation (Met/Arg212Arg) on day 1 p.i. and progressed to up to 3 
mutations containing the substitutions, Gly205Val or Val/Gly, Met/Arg212Arg, Gln226Leu, 
including the silent mutation at position 228. In the contact ferret, the virus was first 
detected on day 7 p.d.c. but contained only one mutation at position Glu190Val.
It was also of interest to investigate whether these HA mutations occurred during the 
mallMD RD transmission experiment. Thus, nasal washes collected from the three mallMD 
inoculated ferrets were also sequenced. The sequencing results revealed that mutations in 
HA1 were confined to the same positions and amino acids that were found in the nasal 
washes of the DC transmission experiment; Gly205Val, Met/Arg212Arg, 228 silent mutation 
(data not shown). However interestingly, no evidence of viruses containing the Gln226Leu 
amino acid substitutions was present. Taken together, these findings identify significant 
amino acid mutations that occurred during H2 virus transmission, including Gln226Leu 
substitution that has been associated with α2,6 sialic acid (human-like) binding preference.
Discussion
The natural emergence of another influenza pandemic virus is considered likely, if not 
inevitable. Public health concerns have mostly centered on the potential of contemporary 
avian influenza subtype viruses to mutate or reassort with other influenza subtypes to a form 
that could become transmissible among humans. As a result, multiple studies have been 
performed to assess the molecular determinants of avian H5, H7 and H9 virus adaptation, 
pathogenicity and transmissibility in mammalian hosts (Maines et al., 2006; Salomon et al., 
2006; Chen et al., 2012; Russell et al., 2012; Herfst et al., 2012; Sorrell et al., 2009). 
However, relatively less attention has been given to H2 subtype viruses largely due to their 
sporadic isolation and low pathogenicity in both avian and mammalian species (Pappas et 
al., 2010; Jones et al., 2014). The isolation of H2N3 influenza viruses from swine in 2006 
focused some awareness and attention to this subtype, and since then, a number of new 
studies have been published that have examined the transmission, pathogenesis and vaccine 
development for this subtype (Nabel et al., 2011; Chen et al., 2010; Killian et al., 2011; 
Pappas et al., 2010; Jones et al., 2014; Driskell et al., 2010). In the present study, we 
examined the pathogenicity and transmissibility of four genetically distinct H2 viruses. All 
four H2 viruses replicated efficiently and transmitted in the direct contact ferret model. As 
efficient replication at the lower temperature of 33 °C is thought to be important for virus 
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adaptation to humans (Pappas et al., 2010; Van Hoeven et al., 2009), we determined the 
optimal replication temperature of each virus. The H2 viruses that transmitted readily by 
respiratory droplets also demonstrated an ability to replicate efficiently at 33 °C—the lower 
temperature found in the environment of the mammalian upper airway. Notably, this 
included the swine H2N3 (swMO) virus that was able to replicate efficiently at 33 °C under 
in vitro conditions and spread to naïve ferrets by respiratory droplets. These results 
prompted us to characterize the swMO virus in more detail by analyzing the receptor 
binding specificity on a glycan array platform and report the crystal structure of swMO HA. 
In addition, we attempted to gain insight into the possible origin of virus diversity by 
sequencing nasal wash samples collected during transmission experiments. The detection of 
viral subpopulations isolated from H2-infected ferrets containing key mutations, such as the 
Gln226Leu change (associated with increased human-like receptor binding preference) is 
important for identifying genetic changes of H2 viruses that can potentially increase its 
transmissibility.
The genetic and antigenic surveillance of avian species in the wild, in farms and in live 
markets has been critical for detection of newly emerging influenza viruses and for 
assessment of potential public health risks (World Health Organization, 2013). This includes 
H2 subtype viruses that are isolated from live bird markets and wild birds, often on an 
annual basis (Piaggio et al., 2012; Makarova et al., 1999; Liu et al., 2004; Kishida et al., 
2008; Ferro et al., 2010; Ramey et al., 2010). The continuous isolation of avian H2 viruses 
increases the risk of human exposure to a novel influenza virus and underscores the need to 
better understand the potential of this subtype to acquire properties that would confer 
efficient RD transmission between mammals. Although there are multiple molecular 
determinants that affect influenza virus host adaptation, it is generally believed that the HA 
of avian virus origin must acquire human influenza virus-like receptor binding (α2,6 SA) 
properties to become transmissible in mammals (Pappas et al., 2010; Maines et al., 2011; 
Pearce et al., 2012; Belser et al., 2013; Tumpey et al., 2007). The avian H2 viruses (ckPA 
and mallMD) tested in this study exhibited classical avian α2,3 SA binding and failed to 
transmit by respiratory droplets. Moreover, both ckPA and mallMD viruses replicated poorly 
at 33 °C, further supporting a lack of adaptation of these avian influenza viruses to 
mammalian hosts. Conversely, the human-adapted H2 (Eng67) virus, which preferentially 
binds to SA in α2–6 linkage and replicated efficiently at 33 °C, transmitted efficiently to 
naïve ferrets by respiratory droplets. Although the avian H2 viruses failed to spread in the 
RD model, the efficient DC transmission results are distinguishable from other avian viruses 
(e.g. H5N1, H7N7) that have shown inefficient transmission in the DC ferret model (Maines 
et al., 2006). Avian influenza viruses that are at least able to spread under close contact 
conditions could possess an advantage over viruses that transmit poorly or not at all. Thus, 
an avian influenza virus that jumps the species barrier to infect an intermediate host, such as 
pigs and subsequently spreads by close contact may result in the generation of a mutant 
virus with adaptive mutations that confers RD transmission. Experimentally, natural virus 
variants with minimal molecular changes have been isolated from exposed ferrets following 
transmission events, such as have been described for H2, H5 and H9 subtype viruses (Pappas 
et al., 2010; Herfst et al., 2012; Sorrell et al., 2009).
Pappas et al. Page 9
Virology. Author manuscript; available in PMC 2018 February 08.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
The swine swMO virus was of particular interest because it has been previously shown to 
replicate well in the respiratory tracts of mammals and transmit efficiently in the DC ferret 
model (Chen et al., 2010; Ma et al., 2007; Richt et al., 2012; Jones et al., 2014). Similarly, 
we found that swMO virus transmitted efficiently in the DC model; however we also 
observed transmission via respiratory droplets in 2/3 exposed ferrets. It is of concern that, in 
addition to its ability to transmit by respiratory droplets, swMO-inoculated ferrets exhibited 
more severe clinical signs (weight loss, lethargy, nasal discharge) and higher virus titers in 
respiratory tract tissues than those in Eng67-inoculated ferrets. In particular, the swine H2N3 
virus demonstrated a tropism for the lower respiratory tract; swMO virus replicated in the 
ferret lung (Fig. 3) and caused gross pathological lung lesions not observed in Eng67-
inoculated ferrets (not shown). These results are consistent with the finding of increased 
swMO virus replication and lesions in lung tissues of macaques compared to that observed 
among human H2N2-infected animals (Chen et al., 2010; Ma et al., 2007; Richt et al., 2012; 
Jones et al., 2014). This work also examined the molecular determinants that might 
influence virulence and transmission of the swine swMO H2N3 virus. Amino acid sequence 
comparison of swMO and other influenza viruses revealed that in addition to the presence of 
226Leu in HA1, swMO virus contains the triple-reassortant internal gene (TRIG) cassette 
similar to H3N2v and A (H1N1)pdm09 viruses, both of which are capable of RD 
transmission (Pearce et al., 2012; Maines et al., 2009). Additional genetic markers for 
swMO that have been shown to confer viral replication advantages, including its ability to 
replicate at 33 °C, is the presence of the Ser590/Arg591 polymorphism and Ala271in PB2. 
The presence of these aminoacid sequences has been shown as critical elements for 
replication and adaptation of triple reassortant viruses in mammals (Mehle and Doudna, 
2009; Liu et al., 2012; Bussey et al., 2010).
The ferret model was also used to measure the impact of within host ‘quasispecies’ diversity. 
In particular, the HA, which is the major determinant of virus antigenicity and receptor 
binding specificity can mutate during replication and adaptation in mammals (Pappas et al., 
2010). By examining the HA1 amino acid sequences in samples taken from the ferret 
respiratory tracts on day 3 p.i., it was determined that the swine (swMO) and avian H2 
viruses (ckPA, mallMD) contained mutations at distinct amino acid positions. In ckPA-
infected ferret tissues (nasal turbinates or lungs), HA mutations were located at positions 
156 or 200. In mallMD-infected tissue samples, virus mutants with changes at amino acid 
position 212 (Met/Arg) were present and swMO-infected trachea samples in 2/3 ferrets 
contained viruses with 226Gln mutations. Two substitutions, Glu190Gly/Asp and 
Glu216Asp, in the HA of ckPA virus were present in all nasal wash samples collected from 
the inoculated and contact ferret pairs where transmission occurred. Interestingly, the virus 
isolated from the inoculated ferret that did not transmit to its cage mate and possessed no 
mutations at 190 or 216. Instead, a mixed virus subpopulation containing Thr206Pro was 
present. These results suggest that mutations at amino acids 190 and 216 may be involved in 
the transmission of ckPA virus in ferrets via DC, but more investigation is necessary to 
confirm this observation. In addition to the Met/Arg212Arg or 212Met mutations found in 
the mallMD ferrets, Glu190Val, Gly205Val, and Gln226Leu changes were detected in the 
nasal washes of both inoculated and contact ferrets, but not all were present in the same 
virus. The appearance of mutant viruses containing Leu226 in one inoculated and one 
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contact ferret suggested this virus was acquiring adaptive changes during its replication in 
the upper respiratory tract of the ferrets. A more detailed sequencing analysis was performed 
on the viruses obtained from all of the nasal washes collected from the 3 ferrets during the 
course of virus infection. The dynamic changes that mallMD virus underwent during the 
course of infection in the ferrets’ upper respiratory tracts were monitored. Amino acid 
changes were restricted to Glu190Val, Gly205Val, Met/Arg212Arg or 212Met and 
Gln226Leu in all 9 ferrets tested, including the inoculated ferrets used in RD transmission 
experiments (data not shown). It appears that the Leu226 amino acid mutation is not an 
essential contribution to a specific combination of mutations that are necessary for DC 
transmission to occur. Conversely, virus subpopulations containing the Leu226 amino acid 
may or may not require additional amino acid changes at positions Val205 and/or Arg212. 
Furthermore, the appearance of Leu226 in the contact ferret did not necessarily mean that it 
was acquired from the inoculated ferret; but rather, it could have occurred by virus 
adaptation. To understand the possible role of the amino acid mutations of mallMD and 
ckPA in the overall HA structure and/or binding to receptors, we mapped their positions on 
the globular head of H2 HA. Changes in residues located at position 190 (Glu/Val/Gly, in 
ckPA) and 226 (Gln/Leu, in mallMD) are in the RBS and involved in the binding to the 
ligands, while positions 216 (Glu/Asp, in ckPA) and 212 (Met/Arg, in mallMD) are further 
away from the RBS, but close to the HA trimer interface and may affect the local monomer-
monomer interaction (Fig. 5B).
The present work supported previous reports showing that avian H2 viruses have not fully 
adapted to mammals, but can acquire mutations enabling α2,6 SA recognition that permit 
transmission between mammals. The presence of mutations in the two avian viruses during 
replication in the ferret model can be attributed to the incompatibility of avian polymerase to 
the new host and/or to the natural mechanism these viruses have to generate thermostable 
virus subpopulations as a mechanism of virus fitness (Negovetich and Webster, 2010). The 
fact that swMO did not present mutations other than Gln226 may indicate significant 
stability of the HA1 molecule, which is probably a result of the HA structural framework as 
well as the high efficiency of polymerase replication at lower temperature.
Influenza H2 viruses represent a potential pandemic subtype should they acquire a 
mammalian transmissible phenotype. In particular, contemporary H2N3 influenza virus 
appears to be already partially adapted to mammals (Ma et al., 2007; Killian et al., 2011). 
Identification of the molecular determinants that confer viral transmission and receptor-
binding properties of H2 viruses are needed to understand the factors that may lead to the 
emergence of future pandemic influenza viruses. While H2 viruses are isolated at a 
relatively low number each year, the potential for these viruses to acquire a transmissible 
phenotype underscores their pandemic potential.
Materials and methods
Viruses
The two avian viruses, A/chicken/Pennsylvania/298101-4/2004 (ckPA, H2N2) and A/
mallard/Maryland/235/2001 (mallMD, H2N3) were kindly provided by David Swayne (U.S. 
Dept. of Agriculture, Southeastern Poultry Research Laboratory) and A/swine/Missouri/
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2124514/2006 virus (swMO, H2N3) was provided by the University of Minnesota. Stocks of 
the two avian viruses were prepared using 10 day-old embryonated hen’s eggs that were 
incubated at 37 °C for 48 h. The human, A/England/10/1967 (Eng/67, H2N2), and swine 
viruses were propagated using Madin–Darby canine kidney cells (MDCK) as previously 
described (Maines et al., 2006). The genome of each virus stock was confirmed by full 
sequencing to ensure no inadvertent mutations were introduced during propagation of virus. 
All experiments performed using these viruses were conducted in biosafety level 3 level 
containment laboratories with enhancements (BSL-3E) (Richmond, 2007).
Ferret pathogenesis and transmission experiments
Male Fitch ferrets, 8–12 months of age (Triple F Farms, Sayre, PA), serologically negative 
for currently circulating seasonal influenza viruses, were housed in cages placed inside a 
Duo-Flo Bioclean mobile clean unit (Lab Products, Seaford, DE). Pathotyping, direct 
contact (DC) and respiratory droplet (RD) virus transmission experiments were performed 
as described (Maines et al., 2005). Briefly, ferrets were intranasally (i.n.) inoculated with 106 
EID50 of virus in a total volume of 1 mL (0.5 mL/nostril). Nasal wash samples were 
collected from ferrets every other day post-virus inoculation (p.i.), or post-ferret direct 
contact (p.d.c.)/indirect contact p.i.c. ). For determination of virus replication, tissue 
specimens were collected from the ferret’s nasal turbinates, trachea and lungs on day 3 p.i. 
Virus transmission was verified by the presence of H2 virus specific antibodies in 
convalescent serum. Sera were collected on day 21 p.i. for determination of seroconversion 
by hemagglutination inhibition (HI) assay. All ferret experiments were conducted under the 
guidance of the Centers for Disease Control and Prevention’s Institutional Animal Care and 
Use Committee (IACUC) in facilities accredited by the Association for Assessment and 
Accreditation of Laboratory Animal Care International (AAALAC).
Viral protein sequence analysis
Viral RNA was extracted from virus stocks, ferrets’ nasal washes (collected on days 3 or 5 
p.i. and days 5 or 7 p.d.c./p.i.c. ) or tissue homogenate supernatants (day 3 p.i.) using 
QIAamp Viral RNA mini kit (Qiagen, Valencia, CA). Virus gene segments were amplified 
by reverse transcription-PCR using Access Quick (Promega, Madison, WI), followed by gel 
purification of the fragments for sequencing reaction using Big Dye V3.1 Terminator kit and 
analysis using a 3730xl DNA sequencer (Applied Biosystems, Foster City, CA). 
Oligonucleotide primer sequences can be provided upon request. Sequence analysis was 
performed using SeqMan, MegAlign (Lasergene) and BioEdit.
Recombinant swMO HA cloning and expression
The cDNA for the ectodomain of the HA from A/swine/Missouri/2124514/2006 was codon 
optimized and synthesized by GeneArt® (Life Technologies) and subcloned into the 
pAcGP67-B, baculovirus transfer vector (BD Biosciences). The recombinant HA protein 
contained a C-terminal thrombin site followed by a trimerizing sequence (foldon) from the 
bacteriophage T4 fibritin for generating functional trimers, and a His-Tag to aid purification 
(Yang et al., 2010b). Secreted protein was recovered from the culture supernatant and 
purified by metal affinity chromatography and size exclusion chromatography (SEC). For 
structural analyses, the recombinant protein was subjected to thrombin cleavage to remove 
Pappas et al. Page 12
Virology. Author manuscript; available in PMC 2018 February 08.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
the foldon and His-Tag and purified by SEC. Thrombin-treated protein was buffer 
exchanged into 10 mM Tris–HCl and 50 mM NaCl (pH 8.0) and the HAs were concentrated 
to 14 mg/ml for crystallization trials.
Crystallization and data collection
Initial crystallization trials were set up using a Topaz™ Free Interface Diffusion (FID) 
Crystallizer system (Fluidigm Corporation, San Francisco, CA). Following optimization, 
diffraction quality crystals for HA were obtained at 20 °C using sitting drop by vapor 
diffusion against a reservoir solution containing 20% PEG 3000, 0.1 M Tris–HCl pH 7.6. 
Crystals were flash-cooled at 100 K. Data were collected at Advanced Photon Source (APS) 
beamline 22-ID at 100 K and processed with the DENZO-SACLEPACK suite (Otwinowski 
and Minor, 1997). Statistics for data collection are presented in Table 3.
Structure determination and refinement
The swMO HA structure was determined by molecular replacement with Phaser (McCoy et 
al., 2005) using the HA structure from A/Japan/305/1957(H2N2) (H3N2), PDB: 3KU5 
(HA1, 91% identity; HA2, 96% identity) as a search model. Three hemagglutinin monomers 
making one non-crystallographic trimer occupy the asymmetric unit with an estimated 
solvent content of 60% based on a Matthews’ coefficient (Vm) of 3/Da. The model was then 
“mutated” to the correct sequence and rebuilt by Coot (Emsley and Cowtan, 2004), and then 
the protein structures were refined with REFMAC (CCP4, 1994) using TLS refinement 
(Winn et al., 2001) and Phenix refine (Adams et al., 2010). The final model was assessed 
using MolProbity (Davis et al., 2007) and statistics for data processing and refinement are 
presented in Table 2.
Glycan binding analyses
Glycan microarray printing and recombinant HA analyses have been described previously 
(Yang et al., 2010b; Stevens et al., 2004, 2006a, 2006b; Yang et al., 2010a, 2012). 
Supplementary Table 2 lists glycans used in these experiments.
Hemagglutination assays
Hemagglutination assays using resialyated turkey red blood cells were performed as 
previously described with minor modifications (Glaser et al., 2006). Turkey red blood cells 
were enzymatically desialyated using Vibrio cholera Sialidase (Roche-Applied Science, 
Indianapolis, IN), followed by resialylation using either α2–6-(N)-sialyltransferase or α2–3-
(N)-sialyltransferase (Sigma-Aldrich, St. Louis, MO). The HI assay was performed using 
homologous viruses along with 1% turkey red blood cells.
PDB accession code
The atomic coordinates and structure factors of swMO HA are available from the RCSB 
Protein Data Bank (PDB) under accession code 4W8N.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Appendix A. Supplementary information
Supplementary data associated with this article can be found in the online version at http://
dx.doi.org/
Pappas et al. Page 16
Virology. Author manuscript; available in PMC 2018 February 08.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 1. 
Plaque morphology of MDCK cells (London) infected with H2 viruses of human, avian and 
swine origin. For every virus, the same dilution was used to inoculate a confluent cell 
monolayer and was incubated at either 37 °C or 33 °C for 65 h.
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Fig. 2. 
Respiratory droplet transmission experiments using H2 viruses of human, avian and swine 
origin. Each experiment was done in triplicate; ferrets were i.n. inoculated with 106 EID50 of 
virus and placed in individual cages. Twenty four hours later a naïve ferret was housed in 
adjacent cage to allow exchange of respiratory droplets through perforations on the 
adjoining walls. Nasal wash samples were collected from inoculated and indirect ferrets on 
alternating days, starting on day 1 post inoculation/post indirect contact (p.i./p.i.c.). (A) 
Ferrets inoculated with human virus Eng67; (B) swMO; (C) mallMD. Bars with the same 
pattern represent nasal wash titers of inoculated/indirect contact ferret pair, the bars on the 
left side correspond to inoculated ferret and on the right side to the indirect contact ferret.
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Fig. 3. 
Influenza virus titers recovered from respiratory tract ferret tissues. Three ferrets were i.n. 
inoculated with 106 EID50 of Eng67, swMO, mallMD and ckPA, and tissues were collected 
on day 3 p.i. Tissues homogenates were titrated in 10-day embryonated eggs. The limit of 
detection is 1.5 Log10 EID50/g or mL. Each bar represents the average titer for three ferrets, 
plus standard deviation. Significance was determined by student t-test and compared against 
swMO values: *p<0.05, **p<0.1, ***p<0.01.
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Fig. 4. 
Glycan microarray analysis of swMO recombinant HA. Colored bars highlight glycans that 
contain α2–3 SA (blue) and α2–6 SA (red), α2–6/α2–3-mixed SA (purple), N-glycolyl SA 
(green), α2–8 SA (brown), β2–6 and 9-O-acetyl SA, and non-SA (gray). Error bars reflect 
the standard deviation in the signal for six independent replicates on the array. Structures of 
each of the numbered glycans are found in Supplementary Table 2.
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Fig. 5. 
Structural overview of swMO HA. (A) One swMO monomer is shown with the HA1 chain 
colored in green and the HA2 chain in cyan. The locations of the glycosylation sites are 
shown in red sticks. (B) Expanded view of swMO HA RBS with its three structural 
elements, the 130-loop, 190-helix, and 220-loop, colored in purple, red and yellow, 
respectively. Mutations found in the nasal washes of ferrets inoculated with ckPA (colored in 
orange and red sticks) and mallMD (colored in orange and blue sticks). (C) Amino acid 
differences in HA region that contains receptor binding amino acids (HA1 positions 130 to 
230). All structural Figs were generated with MacPyMol (DeLano, 2002).
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Table 3
Data collection and refinement statistics.
Data collection swMO
 Space group P212121
 Cell dimensions 70.29 Å, 160.03 Å, 170.60 Å
90°, 90°, 90°
 Resolution (Å) 50–2.9 (3.00–2.90)a
 Rsym 9.0 (78.7)
 I/σ 20.4 (2.9)
 Completeness (%) 99.8 (100)
 Redundancy 7.2 (7.3)
Refinement
 Resolution (Å) 50–2.9 (2.98–2.90)
 No. of reflections (total) 41,095
 No. of reflections (test) 2170
 Rwork/Rfree 23.3/26.2
 No. of atoms 11,826
 r.m.s.d.—bond length (Å) 0.011
 r.m.s.d.—bond angle (°) 1.416
MolProbityb scores
 Favored (%) 92.6
 Allowed (%) 99.4
 Outliers (%) (No. of residues) 0.6(9/1459)
aNumbers in parentheses refer to the highest resolution shell.
b
Ref. Davis et al. (2007).
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Table 4
Determination of HA1 mutations in viruses extracted from ferret tissues.
ckPA mallMD swMO
156 200 212 226
Virus stock E T M/R L
Nasal turbinates E/K (2/3) T M/R (3/3) L (3/3)
Trachea ND ND R (2/2) Q (2/3)
Lungs E (3/3) T/P (pooled)a R (1/3) M/R (2/3) L (3/3)
ND not possible to obtain enough DNA for sequencing analysis.
Amino acid separated by “/” means the presence of mixed populations containing either amino acid co-replicating in the tissue sample.
a
RNAs from the three ferrets’ tissue homogenates were pooled together before RT-PCR preparation for sequencing.
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